This clinical trial is focused on studying the treatment of acute gout attacks, a condition characterized by sudden and severe pain in the joints, often affecting the hand or foot. The study compares two treatments: Prednisolone and Colchicine. Prednisolone is a type of medication known as a glucocorticosteroid, which helps reduce inflammation and pain. Colchicine is another medication used to treat gout by reducing swelling and pain.

The purpose of the study is to evaluate the effectiveness of these treatments in managing the most severe pain experienced during an acute gout attack. Participants in the study will receive either Prednisolone, Colchicine, or a placebo, which is a substance with no active medication. The study is designed to be double-blind, meaning neither the participants nor the researchers know which treatment each participant is receiving, to ensure unbiased results.

Throughout the study, participants will take the medication orally for a period of up to five days. Researchers will monitor the participants’ pain levels, joint swelling, and overall physical function. The study aims to determine which treatment provides the best relief from pain and improves joint function during an acute gout attack. Participants’ feedback on the success of the treatment and any additional pain relief methods used will also be collected to provide a comprehensive understanding of the treatment’s effectiveness.